159 related articles for article (PubMed ID: 30927302)
1. Transcultural, transdiagnostic, and concurrent validity of a revised metacognitions about symptoms control scale.
Fernie BA; Aoun A; Kollmann J; Spada MM; Nikčević AV
Clin Psychol Psychother; 2019 Jul; 26(4):471-482. PubMed ID: 30927302
[TBL] [Abstract][Full Text] [Related]
2. The Metacognitions about Symptoms Control Scale: Development and Concurrent Validity.
Fernie BA; Maher-Edwards L; Murphy G; Nikčević AV; Spada MM
Clin Psychol Psychother; 2015; 22(5):443-9. PubMed ID: 24899521
[TBL] [Abstract][Full Text] [Related]
3. The association between metacognitions and the impact of Fibromyalgia in a German sample.
Kollmann J; Gollwitzer M; Spada MM; Fernie BA
J Psychosom Res; 2016 Apr; 83():1-9. PubMed ID: 27020069
[TBL] [Abstract][Full Text] [Related]
4. [Psychometric approach of metacognition: Pilot study in clinical population].
Visinet A; Soumet-Leman C; Baptista A; Bungener C; Jouvent R
Encephale; 2017 Apr; 43(2):120-127. PubMed ID: 27349578
[TBL] [Abstract][Full Text] [Related]
5. Metacognitions and Mindful Attention Awareness in Depression: A Comparison Of Currently Depressed, Previously Depressed and Never Depressed Individuals.
Solem S; Hagen R; Wang CE; Hjemdal O; Waterloo K; Eisemann M; Halvorsen M
Clin Psychol Psychother; 2017 Jan; 24(1):94-102. PubMed ID: 26450662
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Serbian version of the Metacognitions Questionnaire-30 in nonclinical and clinical samples.
Marković V; Purić D; Vukosavljević-Gvozden T; Begović A
Clin Psychol Psychother; 2019 Jul; 26(4):458-470. PubMed ID: 30893490
[TBL] [Abstract][Full Text] [Related]
7. The Metacognitions about Gambling Questionnaire: Development and psychometric properties.
Caselli G; Fernie B; Canfora F; Mascolo C; Ferrari A; Antonioni M; Giustina L; Donato G; Marcotriggiani A; Bertani A; Altieri A; Pellegrini E; Spada MM
Psychiatry Res; 2018 Mar; 261():367-374. PubMed ID: 29353763
[TBL] [Abstract][Full Text] [Related]
8. Metacognitions in smoking: Evidence from a cross-cultural validation of the metacognitions about smoking questionnaire in a Turkish sample.
Alma L; Spada MM; Fernie BA; Yilmaz-Samanci AE; Caselli G; Nikčević AV
Psychiatry Res; 2018 Jan; 259():160-168. PubMed ID: 29053986
[TBL] [Abstract][Full Text] [Related]
9. Psychometric characteristics of the Penn State Worry Questionnaire and Metacognitions Questionnaire-30 and metacognitive predictors of worry and obsessive-compulsive symptoms in a Turkish sample.
Yilmaz AE; Gençöz T; Wells A
Clin Psychol Psychother; 2008; 15(6):424-39. PubMed ID: 19115461
[TBL] [Abstract][Full Text] [Related]
10. Testing relationships between metacognitive beliefs, anxiety and depression in cardiac and cancer patients: Are they transdiagnostic?
Anderson R; Capobianco L; Fisher P; Reeves D; Heal C; Faija CL; Gaffney H; Wells A
J Psychosom Res; 2019 Sep; 124():109738. PubMed ID: 31443817
[TBL] [Abstract][Full Text] [Related]
11. Measuring metacognition in cancer: validation of the Metacognitions Questionnaire 30 (MCQ-30).
Cook SA; Salmon P; Dunn G; Fisher P
PLoS One; 2014; 9(9):e107302. PubMed ID: 25215527
[TBL] [Abstract][Full Text] [Related]
12. Psychometric properties of the Persian versions of the Positive Alcohol Metacognitions Scale (Persian-PAMS) and the Negative Alcohol Metacognitions Scale (Persian-NAMS) in alcohol-dependent individuals.
Khosravani V; Zandifar A; Sharifi Bastan F; Kolubinski DC; Amirinezhad A
Addict Behav; 2020 Feb; 101():106113. PubMed ID: 31648141
[TBL] [Abstract][Full Text] [Related]
13. The role of metacognitive beliefs in determining the impact of anomalous experiences: a comparison of help-seeking and non-help-seeking groups of people experiencing psychotic-like anomalies.
Brett CM; Johns LC; Peters EP; McGuire PK
Psychol Med; 2009 Jun; 39(6):939-50. PubMed ID: 19000336
[TBL] [Abstract][Full Text] [Related]
14. The psychometric properties of the Persian version of the metacognitions about Smoking Questionnaire among smokers.
Najafi M; Khosravani V; Shahhosseini M; Afshari A
Addict Behav; 2018 Sep; 84():62-68. PubMed ID: 29627635
[TBL] [Abstract][Full Text] [Related]
15. The metacognitions questionnaire for children: development and validation in a clinical sample of children and adolescents with anxiety disorders.
Bacow TL; Pincus DB; Ehrenreich JT; Brody LR
J Anxiety Disord; 2009 Aug; 23(6):727-36. PubMed ID: 19362445
[TBL] [Abstract][Full Text] [Related]
16. The Metacognitions about Online Gaming Scale: Development and psychometric properties.
Spada MM; Caselli G
Addict Behav; 2017 Jan; 64():281-286. PubMed ID: 26210288
[TBL] [Abstract][Full Text] [Related]
17. Validation of a Chinese version of the short form of Metacognitions Questionnaire (MCQ-30).
Zhang MX; Lei LSM; Wells A; Dang L; Wu AMS
J Affect Disord; 2020 Dec; 277():417-424. PubMed ID: 32866800
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of the Metacognitions Questionnaire 30 in people with epilepsy.
Fisher PL; Cook SA; Noble A
Epilepsy Behav; 2016 Apr; 57(Pt A):185-191. PubMed ID: 26970994
[TBL] [Abstract][Full Text] [Related]
19. Metacognitions, rumination, and worry in personality disorder.
Spada MM; Nikčević AV; Kolubinski DC; Offredi A; Giuri S; Gemelli A; Brugnoni A; Ferrari A; Caselli G
J Affect Disord; 2021 Oct; 293():117-123. PubMed ID: 34175593
[TBL] [Abstract][Full Text] [Related]
20. Metacognitions, worry and sleep in everyday life: Studying bidirectional pathways using Ecological Momentary Assessment in GAD patients.
Thielsch C; Ehring T; Nestler S; Wolters J; Kopei I; Rist F; Gerlach AL; Andor T
J Anxiety Disord; 2015 Jun; 33():53-61. PubMed ID: 26005837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
